Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • V Offline
    V Offline
    Vitus
    wrote on sidst redigeret af
    #941

    Er det mon recepttallene markedet er skuffet over ???

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #942

      Nej, tallene er udmærket. Gevinsthjemtagning velsagtens

      1 Reply Last reply
      0
      • P Offline
        P Offline
        peter12
        wrote on sidst redigeret af
        #943

        Ang productionen af IV versionen https://www.ema.europa.eu/en/documents/product-information/darzalex-epar-product-information_en.pdf

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #944

          Men genmab har på det seneste gerne villet placere sig i toppen af listerne. Både taber- og vinderlisterne. I dag er det så taberlisten.

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #945

            Igen ser vi, at der sker ting og sager, når US åbner. I dag blot nedad. Hele C25 følger med.

            1 Reply Last reply
            0
            • V Offline
              V Offline
              Vitus
              wrote on sidst redigeret af
              #946

              Til Pensionisten: Det var nok for tidligt .......

              1 Reply Last reply
              0
              • K Offline
                K Offline
                Klarussen
                wrote on sidst redigeret af
                #947

                Nej, det er ikke fortidligt. Umuligt at time bunden, men udsalget ser us til at være forbi for i dag, Pensionisten scorer snart kassen
                🙂

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  Klarussen
                  wrote on sidst redigeret af
                  #948

                  God morgen og God Jul 😉
                  https://finance.yahoo.com/news/gmab-good-stock-buy-now-030741830.html?guccounter=1&guce_referrer=aHR0cHM6Ly9maW52aXouY29tLw&guce_referrer_sig=AQAAAHh5PqjD6_0L-HgQAbARC4HQs2VvG608Cf763LxiAP_rfdE0B6_J4bCCrpRDx0jO-XiD41b-8RNFKUE7ErBp1BIs-ru2SH-uwDenoDsstOlW9mQcwQvv5DkJdVGTxVIwf5dmUg2J_IvUpLrzKtkxH5pGGRR2twChw4xtoN3bGQkq

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #949

                    God morgen og god jul. 🙂

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #950

                      Jeg har tilladt mig selv at sove et par timer ekstra. Det var ikke ikke helt tosset. 🙂

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #951

                        I årets 45. og næstsidste afsnit af #investeringspodcasten nominerer Per Hansen og Helge Larsen fem forskellige selskabers direktører, som har gjort den værdiskabende forskel i 2020 for investorerne. Lyt med, og hør hvem kandidaterne til at have gjort den gode forskel er. https://www.proinvestor.com/index.php?p=debat_1&postid=89481

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          Doublo
                          wrote on sidst redigeret af
                          #952

                          Tak for spændende po
                          dcast Helge

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            kkjoel
                            wrote on sidst redigeret af
                            #953

                            Oversigtsartikel i går på Seeking Alpha. Forfatteren skriver: "Since I have been following this company from even before its IPO but have never actually written about it, this is a basic overview article, to be followed by in-depth pieces as appropriate."

                            1 Reply Last reply
                            0
                            • K Offline
                              K Offline
                              kkjoel
                              wrote on sidst redigeret af
                              #954

                              Genmab: An European R&D Behemoth With Long-Term Potential https://seekingalpha.com/article/4395989-genmab-european-r-and-d-behemoth-long-term-potential?utm_medium=email&utm_source=seeking_alpha&mail_subject=gmab-genmab-an-european-r-d-behemoth-with-long-term-potential&utm_campaign=rta-stock-article&utm_content=link-2

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                kkjoel
                                wrote on sidst redigeret af
                                #955

                                Dele af konklusionen: "Genmab is a long-term-accumulate kind of stock. It will have ups and downs, but every down is an opportunity because its pipeline is never-ending." og "Its basic expertise is in antibody technology, which it has expanded to include bsAb (bi-specific mAb) and other variants and drug conjugates."These will continue to run through trials and come to the market, and eventually, we will have another DARZALEX level product."

                                1 Reply Last reply
                                0
                                • K Offline
                                  K Offline
                                  kkjoel
                                  wrote on sidst redigeret af
                                  #956

                                  Sluttende med: "So there's really no end to it, and no long-term negatives in this well-managed company. Although current prices are high, if the stock falls on an adverse ruling in the JNJ case, I am buying because even DARZALEX is just one part of the Genmab story, and I am buying the entire story."

                                  1 Reply Last reply
                                  0
                                  • K Offline
                                    K Offline
                                    kkjoel
                                    wrote on sidst redigeret af
                                    #957

                                    Noget af en flot konklusion.. vi er heldigvis mange, der ser langsigtet på firmaet.

                                    1 Reply Last reply
                                    0
                                    • K Offline
                                      K Offline
                                      kkjoel
                                      wrote on sidst redigeret af
                                      #958

                                      Glædelig jul 🙂 .. og tak til dig, Helge for nettets bedste Genmab side!

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #959

                                        .. som får sin værdi af alle jer vidende og delende aktionærer/debattører.

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #960

                                          Tak.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger